Kostas Stamatopoulos is Director of the Institute of Applied Biosciences at CERTH, the Center for Research and Technology Hellas, in Thessaloniki, Greece. He is also Scientific Collaborator of the Molecular Diagnostics lab of the G. Papanicolaou Hospital in Thessaloniki Greece, under a memorandum of understanding. Following his graduation as a medical doctor in 1990 and clinical hematology experience gained in the Athens University School of Medicine, Dr. Stamatopoulos obtained a PhD in Immunoglobulin genes in B-cell malignancies in 1997.
He has been involved in lymphoma research since 1998 and is a founding member of the IMGT CLL-DB initiative (http://www.imgt.org/CLLDBInterface) and the IG CLL group (http://www.igcll.org), operating under the auspices of ERIC (European Research Initiative on CLL). He has published extensively about the immunobiology of CLL and other lymphomas in several peer-reviewed journals. His current research interests focus on the role of microenvironmental interactions in human lymphomas and the study of antigen receptor gene repertoires in health and disease.